Maxigen Biotech Aug revenue falls to NT$68.5M vs NT$70.3M
Maxigen Biotech Inc. reported August 2026 revenue of NT$68,526,000 versus NT$70,258,000 in 2025. It also posted Jan-Aug revenue of NT$544,170,000 versus NT$521,741,000.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.